MACK DAVID J. 4
4 · BioXcel Therapeutics, Inc. · Filed Apr 1, 2025
Insider Transaction Report
Form 4
MACK DAVID J.
Director
Transactions
- Exercise/Conversion
Common Stock
2025-03-31+1,693→ 8,465 total - Exercise/Conversion
Restricted Stock Units
2025-03-31−1,693→ 11,852 total→ Common Stock (1,693 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]On November 21, 2024, the Reporting Person was granted 20,317 RSUs, vesting in twelve equal installments on the last date of each month beginning on November 30, 2024, subject to his continued service as a Director through the vesting period.